Alterity Therapeutics Ltd
ATHE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001131343
In the last 90 days, Alterity Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.12M in total; no superinvestor holds it.
Other share classesPRNAF
Q4 2025 vs. Q3 2025
How the institutions holding Alterity Therapeutics Ltd changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 16 | 18 | +2 |
| Shares | 334.6K | 325.1K | −9.54K (−2.9%) |
| Value | $1.26M | $1.00M | −$258.2K (−20.5%) |
New holders (4)
Institutions that held Alterity Therapeutics Ltd at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| GAMMA Investing LLC | 790 | $2.43K | 0.00% |
| CoreCap Advisors, LLC | 21 | $65 | 0.00% |
| Tower Research Capital LLC (TRC) | 10 | $31 | 0.00% |
| Motiv8 Investments LLC | 40 | $0 | 0.00% |
Sold out (2)
Institutions that held Alterity Therapeutics Ltd at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| EverSource Wealth Advisors, LLC | 177 | $666 |
| SBI Securities Co., Ltd. | 1 | $4 |